Jim Meyers has been promoted to senior vice president, commercial operations, North America, Gilead Sciences, Inc. Mr. Meyers is responsible for the company's commercial organization in North America, including U.S. and Canadian sales, marketing and commercial operations. He reports to Kevin Young, executive vice president, commercial operations. In this new role, Mr. Meyers will join the company's executive committee.
Mr. Meyers joined the company in 1996 as a regional sales director and relocated to the company's headquarters in 1997 to head the HIV marketing team. In 2001 he was named senior director of U.S. sales, overseeing the expansion of the company's field sales organization for its first HIV product. He was promoted to vice president in 2002, and appointed to the position of vice president of the U.S. commercial organization in 2004. Prior to joining Gilead, Mr. Meyers held positions of increasing responsibility in sales, training, marketing and management with Zeneca Pharmaceuticals and Astra USA.
"Over the last 10 years, Jim has contributed significantly to the growth and success of Gilead's commercial organization," said Mr. Young. "As we extend our commercial presence and expand into new therapeutic areas, Jim's leadership and depth of expertise will ensure we continue to meet our aggressive goals and deliver new medications to those patients most in need."